• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B.BRAUN MEDICAL SAS CELSITE; ACCESS PORT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B.BRAUN MEDICAL SAS CELSITE; ACCESS PORT SYSTEM Back to Search Results
Model Number 4440150
Device Problem Fracture (1260)
Patient Problems Swelling (2091); Palpitations (2467)
Event Date 01/03/2020
Event Type  Injury  
Manufacturer Narrative
Note: product reference (b)(4) is not cleared for sales in the usa, but its catheter is similar to the product reference (b)(4) cleared under #510k130576.Batch history review: we have checked the manufacturing file of batch nr 36948873 of celsite which complies with our specifications and does not present any discrepancy.No other similar complaint has been reported to us on this batch of access ports released in (b)(6) 2019.Investigation results: we received for investigation a celsite access port nr 36948873 with two pieces of catheter and the connection ring.The proximal part of the catheter which was connected to the port measures 6,8 cm.The distal part measures 16 cm long.At the level of the rupture, the catheter present a partial clear cut.The facies is shiny; this is charateristic of a cut with a sharp object.Dimensional measurements: we have measured the returned catheter in order to check its conformity to our specification.The internal and external diameters conform to our requirements.Examination of the x-rays films: the x-ray pictures allow us to see that the rupture occured at the level of the neck, at the tunneling point, just before the catheter entry in the vessel.This suggests that the catheter was damaged during tunneling or suturing of the skin at this level.Conclusion: - the evaluation of the explanted device did not allow us to detect any manufacturing defect.- the catheter presents a clear cut donc by a sharp tool.- the rupture occured at the level of the neck, at the tunneling point.- a swelling was observed on the patient neck, the day after the implantation.According to the above mentioned information and in view of the location of the catheter rupture, we can hypothesis that the catheter rupture is due to the extension of an accidental catheter damage done during the implantation procedure, probably while catheter tunneling or suturing of the skin at this level.The incident is not imputable to the device, no corrective action is envisaged.
 
Event Description
"the port was put on (b)(6) 2019 without complications.(b)(6) 2019 the chemotherapy was given for the first time - there was swelling on the neck, which resolved spontaneously the next day.The port was checked under x-ray with contrast - location and correct working.From (b)(6) 2019 to (b)(6) 2019 the patient's rehabilitation was carried out.(b)(6) 2019 at qualification to chemotherapy, there was no backflow of blood, and the patient reported a feeling of palpitations for several days.The port was not used - chemotherapy was given for peripheral injection.(b)(6) /2020 the patient reported for port control.No retrograde outflow, edema and pain in the port chamber were found when 0.9% was administered.Chest x-ray was performed, which showed detachment of the port catheter fragment.The echocardiography of the heart showed a fragment of the port catheter in the right ventricle.The patient was referred to the cardiology and interventional angiology clinic of the institute of cardiology in warsaw, where the catheter was removed from the heart chamber.Then on (b)(6) 2020 the chamber and the rest of the catheter were removed.During removal of the chamber, a fragment of the catheter was detached again, and the cannula ruptures were found in the place of its connection with the chamber.All port elements have been removed from the patient's body.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELSITE
Type of Device
ACCESS PORT SYSTEM
Manufacturer (Section D)
B.BRAUN MEDICAL SAS
26 rue armengaud
saint cloud, 92210
FR  92210
Manufacturer (Section G)
B.BRAUN MEDICAL SAS FRANCE
30 avenue des temps modernes
chasseneuil du poitou, 86360
FR   86360
Manufacturer Contact
catherine boismenu
30 avenue des temps modernes
chasseneuil du poitou, 86360
FR   86360
MDR Report Key9700285
MDR Text Key192409192
Report Number9612452-2020-00005
Device Sequence Number1
Product Code LJT
UDI-Device Identifier04046964453618
UDI-Public4046964453618
Combination Product (y/n)N
Reporter Country CodePL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Reporter Occupation Other
Type of Report Initial
Report Date 02/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number4440150
Device Lot Number36948973
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/27/2020
Initial Date Manufacturer Received 01/13/2020
Initial Date FDA Received02/12/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/19/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-